Beijing Huakang Tianyi attaches great importance to R&D innovation, establishing a full-chain R&D platform system covering materials research, product design, additive manufacturing, biomechanical testing and clinical translation. The company's R&D center covers over 3,000m², equipped with internationally advanced R&D and testing equipment, forming complete innovation capabilities from basic research to product industrialization.
Backed by a strong R&D team, the company conducts in-depth "industry-university-research-medicine" collaboration with renowned universities and top-tier hospitals, establishing joint laboratories and clinical translation centers. Focusing on frontier directions such as new orthopedic implant materials, 3D-printed personalized customization and trabecular bone bioactive interfaces, we continuously drive technological innovation and product upgrading in high-end medical devices.
Focused on composition optimization, heat treatment processes and surface modification research for titanium alloy, CoCrMo and medical ceramic implant materials. Conducting R&D on hydroxyapatite coating, titanium plasma spraying and sandblasting-acid etching surface activation technologies to enhance implant osseointegration.
Equipped with Selective Laser Melting (SLM) metal 3D printing equipment for titanium alloy trabecular porous structure design and process optimization research, enabling rapid prototyping of personalized custom prostheses. Mastering full additive manufacturing core technology from structure design and parameter optimization to post-processing.
Equipped with universal testing machines, fatigue testers and friction-wear testers for implant static mechanical properties, dynamic fatigue life and articular surface wear performance testing. Simulating long-term mechanical performance under human physiological conditions to ensure clinical safety.
Using 3D CAD modeling, Finite Element Analysis (FEA) and computational fluid dynamics for implant structure optimization design and mechanical simulation verification. Combined with medical imaging data for preoperative planning and personalized prosthesis design, shortening R&D cycles and improving design precision.
Establishing joint clinical research centers with top-tier hospital orthopedics departments for new product preclinical evaluation, clinical trial design and postoperative follow-up research. Translating clinical needs into product R&D directions and accelerating research outcomes to clinical application.
Conducting cytotoxicity, sensitization, irritation, genotoxicity and implantation biological evaluation tests, establishing product biocompatibility evaluation systems to ensure all implant products meet ISO 10993 international standards for biological performance.
R&D Center Area
Specialized R&D Platforms
Collaboration Institutions
Annual R&D Investment Ratio
